Hyundai Bioscienceis A Biotechnology Company Dedicated To Developing Innovativeantiviral And Anticancer Therapeutics By Leveraging Cutting Edgedrug Delivery Systemsdds Our Proprietary Nanohybrid Dds Technologies Enhancethebioavailability Of Activepharmaceutical Ingredientsapisand Improvetargeted Drug Deliverymaximizing Therapeutic Efficacy Whileminimizing Adverseeffects Our Coretechnologies & Products Y Xaftyaaea Broad Spectrum Oral Antiviral Drug Candidatebased On Niclosamidetargeting Covid 19Long Coviddengueinfluenzarsvmpoxadenovirusand Other Infectious Diseases Y Polytaxelaaea Pain Freeanticancer Treatmentutilizing A Nanoparticlebased Dds To Enhancethebioavailability And Therapeutic Effects Of Docetaxelreducing Toxicity And Sideeffects Whileimproving Tumor Selectivity Y Penetriuma Ccp Pca07Aeapproved For Phase1 Clinical Trials In South Korea For Castration Resistant Prostatecancercrpc Penetriuma C Aims To Address Non Genetic Resistancepseudo Resistancein Combination With Existing Therapiesoffering New Potential Solutions For Resistant Cancer Types Y Otx Ma C Aean Oral Metronomic Chemotherapy Using Docetaxeldesigned To Sustain Anticancer Effectsminimizetoxicityand Improvepatient Quality Of Lifeby Enabling Long Termlow Dosetreatment Strategies What Weofferaoe Innovativedrug Delivery Systemsddsaeenhancing Drug Solubilitystabilityand Targeted Delivery Through Proprietary Nanohybrid Formulations Aoe Broad Spectrum Antiviral Therapeutics Aedeveloping Oral Antiviral Treatments To Address Global Pandemic Preparedness And Neglected Infectious Diseases Aoe Next Generation Oncology Solutions Aeadvancing Pain Freetargetedand Metronomic Chemotherapy To Improvecancer Treatment Efficacy And Safety With A Strong Commitment To Scientific Innovation And Patient Centric Therapieshyundai Bioscienceis Redefining Thefutureof Antiviral And Oncology Drug Development
